跳至主要内容
临床试验/JPRN-UMIN000053278
JPRN-UMIN000053278尚未招募未知

Retrospective observational study comparing comparing post-COVID conditions incidence in COVID-19 patients between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan (3-month follow-up) - Retrospective observational study comparing comparing post-COVID conditions incidence in COVID-19 patients between ensitrelvir administration and administration/non-administration of anti-SARS-CoV-2 drugs using large-scale health insurance association data in Japan (3-month follow-up)

Shionogi & Co., Ltd.0 个研究点目标入组 300,000 人开始时间: 2024年1月9日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
300,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients under 18 years of age at the time of IM 2. Patients with dispending days of multiple anti-SARS-CoV-2 drugs in IM 3. Patients with a COVID-19 diagnosis within 3 months prior to IM 4. Patients who have been diagnosed with the same event as the post-COVID condition within 6 months before IM 5. Patients at risk of severe COVID-19

研究者

发起方
Shionogi & Co., Ltd.

相似试验